Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

Presentation

What the Dermatologist Needs to Know About Genetic Testing

Description

This talk by a dermatologist with genetics training addresses the complexities of ordering genetic tests in dermatology. The speaker shares experiences with genetic testing, illustrating the challenges encountered when patients receive test kits without clear instructions. The discussion includes types of genetic tests, such as chromosomal microarrays, multi-gene panels, and whole exome sequencing, explaining when to use them based on clinical presentations. For instance, a case is presented where a six-year-old patient with scaly skin might be evaluated for ichthyosis using a chromosomal microarray. The talk emphasizes the importance of understanding test reports, parental testing implications, and distinguishing between germline and somatic mutations, especially in conditions like sebaceous carcinoma and Lynch syndrome. The lecturer highlights the need for thorough communication, patient follow-up, and integration of resources like genetic counselors to guide clinical decision-making and ensure appropriate care based on genetic findings. The speaker concludes by encouraging dermatologists to recognize the indications for genetic tests in practice and to keep up with evolving genetic testing technologies and interpretations.

View more

Conclusions

Dermatologists need to understand the applications and limitations of various genetic tests such as chromosomal microarray and whole exome sequencing.
Chromosomal microarray is recommended as first-line testing for multiple anomalies and developmental delays.
A negative genetic test may not provide meaningful information and should not be considered truly negative.
Patients may require genetic counseling and support for decision-making about testing.
Testing for certain disorders, such as X-linked ichthyosis and basal cell nevus syndrome, should follow specific guidelines for selection of appropriate tests.
Familial testing is often necessary for accurate interpretation of genetic test results and understanding inheritance patterns.
New technologies in genetic testing may yield additional insights which can change interpretations over time, necessitating follow-up and re-evaluation of results.
The importance of understanding somatic versus germline mutations is growing, particularly in cancers such as sebaceous carcinoma and melanoma.
Genetic testing recommendations and interpretations are evolving, and dermatologists must stay informed about recent developments and guidelines.

Wagoner et al. ACMG Practice Resource. Genetics in Medicine. June 2018.
Shi G et al. J Peds; 2022. 243 (219-223).
Langlois S et al. Prenatal diagnosis. 2009; 29(10):966-74.
Chau MHK, Cao Y et al. Characteristics and mode of inheritance. Am J Ob Gyn; 2019 June.
Muller, et al ., Am J Med Genet, 2012.
Merker VL et al. Outcomes of preimplation genetic diagnosis in Neurofibromatosis type 1. Fert Steril 2015; 130(3) 761-768.
Fernandez LT et al. Int J Dermatol 2022; 61, 1047-1055.